Skip to content

Case Review of the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery

The Prism Trial: A Retrospective Case Review of Technical Success Using the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02085551
Acronym
PRISM
Enrollment
85
Registered
2014-03-13
Start date
2014-03-31
Completion date
2015-09-30
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Arterial Occlusion or Emboli

Keywords

peripheral arterial occlusion, visceral emboli, limb ischemia, adverse events, Indigo System, aspiration, mechanical thrombectomy

Brief summary

The primary objective of this retrospective case review study is to determine the safety and effectiveness of the Penumbra and Indigo Systems for mechanical thrombectomy in a cohort of patients with confirmed peripheral or visceral arterial occlusion or embolus. This is a retrospective, single arm, multi-center trial. Up to 100 patients at up to 10 centers will be enrolled. Angiographic assessment of vessel patency at immediate post-procedure as measured by TIMI scores and procedural serious adverse events are assessed and recorded.

Interventions

DEVICEMechanical Thrombectomy by the Indigo System

Sponsors

Penumbra Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Evidence of a peripheral or visceral arterial occlusion or embolus (TIMI 0-1) prior to treatment. * Treatment with components of the Penumbra and/or Indigo System.

Exclusion criteria

* Participation in another clinical investigation that may confound the results of the study.

Design outcomes

Primary

MeasureTime frameDescription
Angiographic Assessment of Vessel Patency at Immediate Post-procedure as Measured by TIMI ScoresImmediate post-procedureProportion of patients with a post-procedure TIMI score of 2 to 3.
Procedural Serious Adverse EventsDuring the procedure

Countries

United States

Participant flow

Participants by arm

ArmCount
Mechanical Thrombectomy by the Indigo System
Mechanical Thrombectomy by the Indigo System
85
Total85

Baseline characteristics

CharacteristicMechanical Thrombectomy by the Indigo System
Age, Continuous68.5 Years
STANDARD_DEVIATION 12.6
Region of Enrollment
United States
85 participants
Sex: Female, Male
Female
35 Participants
Sex: Female, Male
Male
50 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 85
other
Total, other adverse events
27 / 85
serious
Total, serious adverse events
15 / 85

Outcome results

Primary

Angiographic Assessment of Vessel Patency at Immediate Post-procedure as Measured by TIMI Scores

Proportion of patients with a post-procedure TIMI score of 2 to 3.

Time frame: Immediate post-procedure

Population: TIMI score at immediate post-procedure was unavailable for one patient.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Mechanical Thrombectomy by the Indigo SystemAngiographic Assessment of Vessel Patency at Immediate Post-procedure as Measured by TIMI Scores74 Participants
Primary

Procedural Serious Adverse Events

Time frame: During the procedure

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Mechanical Thrombectomy by the Indigo SystemProcedural Serious Adverse Events5 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026